Pharma Mar SA
OTC:PHMMF
Pharma Mar SA
Net Income (Common)
Pharma Mar SA
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pharma Mar SA
MAD:PHM
|
Net Income (Common)
€2m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
Grifols SA
MAD:GRF
|
Net Income (Common)
€59.3m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Oryzon Genomics SA
MAD:ORY
|
Net Income (Common)
-€3.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Biotechnology Assets SA
MAD:BST
|
Net Income (Common)
€1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharma Mar SA's Net Income (Common)?
Net Income (Common)
2m
EUR
Based on the financial report for Mar 31, 2024, Pharma Mar SA's Net Income (Common) amounts to 2m EUR.
What is Pharma Mar SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-17%
Over the last year, the Net Income (Common) growth was -93%. The average annual Net Income (Common) growth rates for Pharma Mar SA have been -72% over the past three years , and -17% over the past ten years .